LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹3.12 Cr | ₹0.23 Cr | ₹0.23 Cr | ₹0.23 Cr | ₹1.46 Cr |
What is the latest Contingent Liabilities ratio of LINCOLN PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹3.12 Cr |
| Mar2024 | ₹0.23 Cr |
| Mar2023 | ₹0.23 Cr |
| Mar2022 | ₹0.23 Cr |
| Mar2021 | ₹1.46 Cr |
How is Contingent Liabilities of LINCOLN PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.12 Cr | 1,250.65 | |
| Mar2024 | ₹0.23 Cr | 0.00 | |
| Mar2023 | ₹0.23 Cr | 0.00 | |
| Mar2022 | ₹0.23 Cr | -84.22 | |
| Mar2021 | ₹1.46 Cr | - | |
Compare Contingent Liabilities of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,281.1 Cr | 3.8% | 7.5% | 13.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,339.0 Cr | -2.7% | -3.7% | 20.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,068.0 Cr | 3.7% | 15.7% | 51% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,767.0 Cr | -0.8% | 1% | 36.2% | Stock Analytics | |
| CIPLA | ₹111,804.0 Cr | -2.1% | -5.2% | -11.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,113.4 Cr | -0.8% | -0.5% | -9.3% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | 3.8% |
7.5% |
13.6% |
| SENSEX | -1.8% |
-3.7% |
-5.7% |
You may also like the below Video Courses